SPEAKERS: Harry Southworth (Data Clarity Consulting Limited) and Janet Heffernan (J. Heffernan Consulting)
Extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 361–366, September/October 2012 Abstract | Paper+
Multivariate extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 367–372, September/October 2012 Abstract | Paper+
SPEAKERS: Harry Southworth (Data Clarity Consulting Limited) and Janet Heffernan (J. Heffernan Consulting)
Extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 361–366, September/October 2012 Abstract | Paper+
Multivariate extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 367–372, September/October 2012 Abstract | Paper+
SPEAKERS: Harry Southworth (Data Clarity Consulting Limited) and Janet Heffernan (J. Heffernan Consulting)
Extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 361–366, September/October 2012 Abstract | Paper+
Multivariate extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 367–372, September/October 2012 Abstract | Paper+
SPEAKERS: Harry Southworth (Data Clarity Consulting Limited) and Janet Heffernan (J. Heffernan Consulting)
Extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 361–366, September/October 2012 Abstract | Paper+
Multivariate extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 367–372, September/October 2012 Abstract | Paper+
SPEAKERS: Harry Southworth (Data Clarity Consulting Limited) and Janet Heffernan (J. Heffernan Consulting)
Extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 361–366, September/October 2012 Abstract | Paper+
Multivariate extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 367–372, September/October 2012 Abstract | Paper+
SPEAKERS: Harry Southworth (Data Clarity Consulting Limited) and Janet Heffernan (J. Heffernan Consulting)
Extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 361–366, September/October 2012 Abstract | Paper+
Multivariate extreme value modelling of laboratory safety data from clinical studies
Authors: Harry Southworth and Janet E. Heffernan;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 367–372, September/October 2012 Abstract | Paper+
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Date: The Second Wednesday of every Month
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Date: Tuesday 10th December 2024
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Date: Thursday 12th December 2024
Chaired by Jenny Devenport, join us to hear Andy Grieve and Zhiwei Zhang discuss their recent work on group sequential designs.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
Date: October 2024 - July 2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
PSI Training Course: Mixed Models and Repeated Measures
Dates:
Monday 3rd February 2025: 08:30-13:00 BST
Tuesday 4th February 2025: 08:30 - 13:00 BST
Wednesday 5th February 2025: 08:30 - 13:00 BST
Thursday 6th February 2025: 08:30 - 13:00 BST
This course is presented through lectures and practical sessions using SAS code. It is suitable for statisticians working on clinical trials, who already have a good understanding of linear and generalised linear models.